Nadja C. Fenn

Bifunctional PD-1 × αCD3 × αCD33 fusion protein reverses adaptive immune escape in acute myeloid leukemia

Monika Herrmann, Christina Krupka, Katrin Deiser et al. · Blood · 2018 · 104 citations · Full text

Medicine, Immunology, Oncology +14

A modular and controllable T cell therapy platform for acute myeloid leukemia

Mohamed-Reda Benmebarek, Bruno L. Cadilha, Monika Herrmann et al. · Leukemia · 2021 · 34 citations · Full text

Medicine, Immunology, Oncology +17

Dual-targeting triplebody 33-16-123 (SPM-2) mediates effective redirected lysis of primary blasts from patients with a broad range of AML subtypes in combination with natural killer cells

Todd A. Braciak, Claudia C. Roskopf, Sarah Wildenhain et al. · OncoImmunology · 2018 · 33 citations · Full text

Medicine, Hematology, Immunology +16

CD19-specific triplebody SPM-1 engages NK and γδ T cells for rapid and efficient lysis of malignant B-lymphoid cells

Christian Schiller, Todd A. Braciak, Nadja C. Fenn et al. · Oncotarget · 2016 · 32 citations · Full text

Medicine, Hematology, Immunology +11

SIRPα-αCD123 fusion antibodies targeting CD123 in conjunction with CD47 blockade enhance the clearance of AML-initiating cells

Siret Tahk, Binje Vick, Björn Hiller et al. · Journal of Hematology & Oncology · 2021 · 31 citations · Full text

Medicine, Immunology, Oncology +16